1. Home
  2. ALGT vs VRDN Comparison

ALGT vs VRDN Comparison

Compare ALGT & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allegiant Travel Company

ALGT

Allegiant Travel Company

HOLD

Current Price

$78.07

Market Cap

2.1B

ML Signal

HOLD

Logo Viridian Therapeutics Inc.

VRDN

Viridian Therapeutics Inc.

HOLD

Current Price

$21.95

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALGT
VRDN
Founded
1997
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.1B
IPO Year
2006
2014

Fundamental Metrics

Financial Performance
Metric
ALGT
VRDN
Price
$78.07
$21.95
Analyst Decision
Hold
Strong Buy
Analyst Count
10
14
Target Price
$97.30
$35.46
AVG Volume (30 Days)
489.7K
1.1M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
81.62
N/A
EPS
1.80
N/A
Revenue
$2,606,579,000.00
$5,706,000.00
Revenue This Year
$9.42
$13.73
Revenue Next Year
$6.52
$279.00
P/E Ratio
$43.96
N/A
Revenue Growth
3.74
N/A
52 Week Low
$57.11
$13.18
52 Week High
$123.63
$34.29

Technical Indicators

Market Signals
Indicator
ALGT
VRDN
Relative Strength Index (RSI) 44.06 46.44
Support Level $74.61 $21.40
Resistance Level $86.26 $23.84
Average True Range (ATR) 2.87 0.88
MACD 1.04 -0.24
Stochastic Oscillator 66.27 28.87

Price Performance

Historical Comparison
ALGT
VRDN

About ALGT Allegiant Travel Company

Allegiant Travel Co is a leisure travel company focused on providing travel and leisure services and products to residents of underserved cities in the United States. It operates a low-cost, low utilization passenger airline marketed to leisure travelers in underserved cities, allowing it to sell air transportation both on a stand-alone basis and bundled with the sale of air-related and third-party services and products. In addition, it provides air transportation under fixed-fee flight arrangements. In connection with its leisure travel focus, the company has opened Sunseeker Resort Charlotte Harbor, equipped with several guestrooms and food and beverage outlets. The company's operating segments are the Airline, which generates the maximum revenue, and Sunseeker Resort.

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligrotug for intravenous (IV) administration and elegrobart (formerly VRDN-003) for subcutaneous (SC) administration, to treat patients with TED. Our most advance program, veligrotug, is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of TED.

Share on Social Networks: